Probing the mechanisms of intradialytic hypertension: A pilot study targeting endothelial cell dysfunction

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 8, 2012, Pages 1300-1309

  Inrig, Jula K ^a,b   Van Buren, Peter ^a   Kim, Catherine ^a   Vongpatanasin, Wanpen ^a   Povsic, Thomas J ^b   Toto, Robert ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDEHYDE DEHYDROGENASE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIANEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; CD133 ANTIGEN; CD34 ANTIGEN; CINACALCET; CLONIDINE; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; GLYCERYL TRINITRATE; HYDRALAZINE; HYPOCHOLESTEROLEMIC AGENT; IRON; ISOSORBIDE; LABETALOL; N(G),N(G) DIMETHYLARGININE; PHOSPHATE BINDING AGENT; PHOSPHODIESTERASE V INHIBITOR; VITAMIN D DERIVATIVE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ANTIGEN EXPRESSION; ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; ARTERY DILATATION; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BRACHIAL ARTERY; BRADYCARDIA; CAROTID ARTERY; CELL DAMAGE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG DOSE TITRATION; DRUG SAFETY; DRUG TOLERABILITY; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; ENDOTHELIUM CELL DYSFUNCTION; ENZYME ACTIVITY; FEMALE; FEMORAL ARTERY; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; HYPOTENSION; IATROGENIC DISEASE; INTRADIALYTIC HYPERTENSION; MALE; PILOT STUDY; PNEUMONIA; PROTEIN BLOOD LEVEL; PULSE WAVE; SIDE EFFECT; STOMACH PARESIS; SYSTOLIC BLOOD PRESSURE; TARGET CELL; WEIGHT GAIN;

ADULT; AGED; ALDEHYDE DEHYDROGENASE; ANTIGENS, CD; ANTIGENS, CD34; ANTIHYPERTENSIVE AGENTS; ARGININE; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; BODY WEIGHT; CARBAZOLES; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FEMALE; GLYCOPROTEINS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PEPTIDES; PILOT PROJECTS; PROPANOLAMINES; PROSPECTIVE STUDIES; RENAL DIALYSIS; STEM CELLS; TEXAS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR STIFFNESS; VASODILATION; VASODILATOR AGENTS;

EID: 84864799371     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.10010911     Document Type: Article

References (26)

1. Inrig JK: Intradialytic hypertension: A less-recognized cardiovascular complication of hemodialysis. AmJ KidneyDis 55: 580-589, 2010
2. Inrig JK, Oddone EZ, HasselbladV, GillespieB, PatelUD, ReddanD, Toto R, Himmelfarb J, Winchester JF, Stivelman J, Lindsay RM, Szczech LA: Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients. Kidney Int 71: 454-461, 2007
3. Inrig JK, Patel UD, Toto RD, Reddan DN, Himmelfarb J, Lindsay RM, Stivelman J, Winchester JF, Szczech LA: Decreased pulse pressure during hemodialysis is associated with improved 6-month outcomes. Kidney Int 76: 1098-1107, 2009
4. Inrig JK, Patel UD, Toto RD, Szczech LA: Association of blood pressure increases during hemodialysis with 2-year mortality in incident hemodialysis patients: A secondary analysis of the Dialysis Morbidity and MortalityWave 2 Study. AmJ Kidney Dis 54: 881-890, 2009
5. Inrig JK, Van Buren P, Kim CM, VongpatanasinW, Povsic TJ, Toto RD: Intradialytic hypertension and its association with endothelial cell dysfunction. Clin J Am Soc Nephrol 6: 2016-2024, 2011
6. Chou KJ, Lee PT, Chen CL, Chiou CW, Hsu CY, Chung HM, Liu CP, Fang HC: Physiological changes during hemodialysis in patients with intradialysis hypertension. Kidney Int 69: 1833-1838, 2006
7. Raj DS, Vincent B, Simpson K, Sato E, Jones KL, Welbourne TC, Levi M, Shah V, Blandon P, Zager P, Robbins RA: Hemodynamic changes during hemodialysis: Role of nitric oxide and endothelin. Kidney Int 61: 697-704, 2002
8. CiritM, Akiek F, Terzioglu E, Soydasx C, Ok E, Ozbasxli CF, BasxiA, Mees EJ: 'Paradoxical' rise in blood pressure during ultrafiltration in dialysis patients. Nephrol Dial Transplant 10: 1417-1420, 1995
9. Bazzato G, Coli U, Landini S, Lucatello S, Fracasso A, Morachiello P, Righetto F, Scanferla F: Prevention of intra-and postdialytic hypertensive crises by captopril. Contrib Nephrol 41: 292-298, 1984
10. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G: Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353: 999-1007, 2005
11. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600, 2003
12. London GM, Pannier B, Agharazii M, Guerin AP, Verbeke FH, Marchais SJ: Forearm reactive hyperemia and mortality in endstage renal disease. Kidney Int 65: 700-704, 2004
13. Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Nedeljkovic ZS, Menzoian JO, Vita JA: Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 41: 1769-1775, 2003
14. Saijonmaa O, Metsärinne K, Fyhrquist F: Carvedilol and its metabolites suppress endothelin-1 production in human endothelial cell culture. Blood Press 6: 24-28, 1997
15. Bank AJ, Kelly AS, Thelen AM, Kaiser DR, Gonzalez-Campoy JM: Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus. AmJ Hypertens 20: 777-783, 2007
16. Povsic TJ, Adams SD, Zavodni KL, Kelly F, Melton LG, Rao SV, Najjar SS, Harrington RA, Peterson ED: Aldehyde dehydrogenase activity allows reliable EPC enumeration in stored peripheral blood samples. J Thromb Thrombolysis 28: 259-265, 2009
17. Povsic TJ, Zavodni KL, Vainorius E, Kherani JF, Goldschmidt-Clermont PJ, Peterson ED: Common endothelial progenitor cell assays identify discrete endothelial progenitor cell populations. Am Heart J 157: 335-344, 2009
18. Povsic TJ, Zavodni KL, Kelly FL, Zhu S, Goldschmidt-Clermont PJ, Dong C, Peterson ED: Circulating progenitor cells can be reliably identified on the basis of aldehyde dehydrogenase activity. J Am Coll Cardiol 50: 2243-2248, 2007
19. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R; International Brachial Artery Reactivity Task Force: Guidelines for the ultrasound assessment of endothelial-dependent flowmediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39: 257-265, 2002
20. Pyke KE, Tschakovsky ME: The relationship between shear stress and flow-mediated dilatation: Implications for the assessment of endothelial function. J Physiol 568: 357-369, 2005
21. Harris RA, Nishiyama SK, Wray DW, Richardson RS: Ultrasound assessment of flow-mediated dilation. Hypertension 55: 1075-1085, 2010
22. Bahous SA, Stephan A, BarakatW, Blacher J, Asmar R, Safar ME: Aortic pulse wave velocity in renal transplant patients. Kidney Int 66: 1486-1492, 2004
23. Park CS, Kim W, Woo JS, Ha SJ, Kang WY, Hwang SH, Park YW, Kim YS, Ahn YK, Jeong MH, Kim W: Green tea consumption improves endothelial function but not circulating endothelial progenitor cells in patients with chronic renal failure. Int J Cardiol 145: 261-262, 2010
24. Yoshida O, Kondo T, Kureishi-Bando Y, Sugiura T, Maeda K, Okumura K, Murohara T: Pitavastatin, an HMG-CoA reductase inhibitor, ameliorates endothelial function in chronic smokers. Circ J 74: 195-202, 2010
25. Agarwal R: Supervised atenolol therapy in the management of hemodialysis hypertension. Kidney Int 55: 1528-1535, 1999
26. Van Buren PN, Kim C, Toto R, Inrig JK: Intradialytic hypertension and the association with interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol 6: 1684-1691, 2011